Anavex Gets FDA Approval For Orphan Drug Designation for Frontotemporal Dementia Treatment
April 08, 2016 at 08:11 AM EDT
Anavex Life Sciences Corp (OTC: AVXL) said the FDA has granted orphan drug status to its ANAVEX 3-71 for frontotemporal dementia or ...